Notice of Clarification of NIMH Specific Areas of Research Interest in PAR-24-144 and PAR-24-145, "Support for Research Excellence (SuRE) and (SuRE-First) Awards (R16 - Clinical Trial Not Allowed)
Notice Number:
NOT-MH-24-250

Key Dates

Release Date:

April 23, 2024

Related Announcements

  • March 14, 2024 - Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed). See NOFO PAR-24-144
  • March 14, 2024 - Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed). See NOFO PAR-24-145

Issued by

National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to clarify the National Institute of Mental Health (NIMH) research priorities in PAR-24-144, "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)" and PAR-24-145, "Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed).

NIMH Area of Interest: The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. NIMH supports research on topics that include basic neuroscience and behavioral science, and translational application of brain and behavior relationships in healthy and diseased states. Applications considered for funding by the NIMH must fall within the areas of priority detailed in the NIMH Strategic Plan and the NIMH Strategic Research Priorities. It is recommended that investigators contact NIMH Scientific/Research staff well in advance of submitting applications to discuss the match to NIMH priorities.

Inquiries

Please direct all inquiries to:

Brittany Haynes, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-496-2767
Email: [email protected]